Myeloma protocols (printable versions)
Archived protocols
(printable versions)
MM.55 Belantamab Mafodotin
Printable version
MM.3 Bone Protection in Myeloma
Printable version
MM.4 Bortezomib (Velcade) 21 day
Printable version
MM.5 Bortezomib (Velcade) 35 day
Printable version
MM.6 Bortezomib (Velcade), Lenalidomide and Dexamethasone (VRD)
Printable version
MM.7 Bortezomib (Velcade), Thalidomide and Dexamethasone (VTD)
Printable version
MM.8 Bortezomib (Velcade), Thalidomide and Dexamethasone (VTD) 28 day cycle
Printable version
MM.39 Carfilzomib & Dexamethasone
Printable version
MM.53 Carfilzomib with Pomalidomide & Dexamethasone
Printable version
MM.34 CarLenDex
Printable version
MM.9 CTD - attenuated
Printable version
MM.10 CTD - full dose
Printable version
MM.11 CyBorDex Amyloidosis protocol
Printable version
MM.12 Cyclophosphamide / Bortezomib (Velcade) / Dexamethasone (CyBorDex)
Printable version
MM.28 Cyclophosphamide / Carfilzomib / Dexamethasone (CyCarDex)
Printable version
MM.13 Cyclophosphamide (oral) +/- Prednisolone
Printable version
MM.32 Daratumumab Monotherapy
Printable version
MM.58 Daratumumab with Bortezomib, Cyclophosphamide and Dexamethasone
Printable version
MM.56 Daratumumab with Bortezomib, Thalidomide and Dexamethasone
Printable version
MM.38 Daratumumab with Lenalidomide and Dexamethasone
Printable version
MM.51 Daratumumab with Pomalidomide and Dexamethasone
Printable version
MM.47 Daratumumab with Velcade and Dexamethasone
Printable version
MM.48 Daratumumab Rapid Rate Infusion
Printable version
MM.14 Dexamethasone - high dose
Printable version
B.36 Filgrastim - biosimilar
Printable version
MM.16 Intermediate dose Melphalan with Dexamethasone
Printable version
MM.52. Isatuximab with Pomalidomide and Dexamethasone
Printable version
MM.33 Ixazomib with Lenalidomide and Dexamethasone
Printable version
MM.17 Lenalidomide, Cyclophosphamide and weekly Dexamethasone
Printable version
MM.59 Lenalidomide Maintenance
Printable version
MM.18 Lenalidomide with Dexamethasone
Printable version
MM.19 Melphalan, Bortezomib (Velcade), Prednisolone (MelBorPred)
Printable version
MM.20 Melphalan +/- Prednisolone
Printable version
MM.21 Melphalan, Prednisolone and Thalidomide (MPT)
Printable version
MM.31 Panobinostat/Bortezomib (Velcade)/Dexamethosone (PanBorDex)
Printable version
MM.22 Pomalidomide and low dose Dexamethasone (IMNOVID)
Printable version
MM.49 Pomalidomide Bortezomib and Dexamethasone (PVD) 21 day Cycle
Printable version
MM.26 Siltuximab IV (Sylvant ®)
Printable version
MM.23 Thalidomide +/- Dexamethasone
Printable version
MM.50 VTDPACE / DTPACE
Printable version
MM.25 Z-DEX
Printable version
C-VAMP
Printable version
VAD
Printable version
NICE approvals 2013
Return to
Myeloma page
Return to
Home page